Thanks to you and thousands of ECAN advocates, Esophageal Cancer was included in the Department of Defense (DoD) Peer-Reviewed Cancer Research Program (PRCRP) for the first time in FY 2020. As a result, in Esophageal Cancer researchers were able to gain nearly $4.5 million in additional research funding in 2021! Those funds will fuel a clinical trial for cutting-edge therapy and a study of new screening methods.
Last year, Congress voted to include Esophageal Cancer in the PRCRP once again – this time appropriating $115 million for the PRCRP. Esophageal Cancer researchers will begin submitting their grant proposals to the program in the coming months. In the meantime, ECAN hosted a webinar for researchers to learn about how they can access this funding. Researchers are encouraged to watch the recording of this webinar here.
Find out more about the Peer-Reviewed Cancer Research Program and how Esophageal Cancer qualifies by clicking here.
Take Action Now to Make Millions More Available in 2022!
While getting in the program for the first time was a huge win, and the second year was a great success, this is just the beginning.
Each year, Congress is required to re-write the list of cancers that are eligible for research funding under the program.
Thanks to our ECAN advocates, 44 U.S. Representatives signed a letter supporting keeping Esophageal Cancer included as a disease eligible for funding under the PRCRP for FY22. Now, we need to focus on getting Senate support.
Our easy-to-use platform takes just a couple of minutes for you to
let your Senators know that you expect them to stand up for those at risk for Esophageal Cancer and
take action to keep Esophageal Cancer in the PRCRP!